Targeted Genetics starts Phase II gene therapy study

TGEN began a 36-patient placebo controlled U.S.

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE